Jan 27, 2023
Epigenetically programmed resistance to chemo- and immuno-therapies.
Walker RR, Rentia Z, Chiappinelli KB. Adv Cancer Res. Jan 27 2023;158:41-71. doi:10.1016/bs.acr.2022.12.001.
Dec 7, 2022
PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling.
Raja, R., Wu, C. L., Rubino, T. E., Utagawa, E., Magtibay, P. M., Butler, K. A., & Curtis, M. Journ. Immunotherapy of Cancer vol 19, no 12. 2022 Dec 1; e005026 DOI: 10.1136/jitc-2022-005026
Nov 7, 2022
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer
Gomez, S., Cox, O. L., Walker, R. R., 3rd, Rentia, U., Hadley, M., Arthofer, E., Diab, N., Grundy, E. E., Kanholm, T., McDonald, J. I., Kobyra, J., Palmer, E., Noonepalle, S., Villagra, A., Leitenberg, D., Bollard, C. M., Saunthararajah, Y., & Chiappinelli, K. B. J Immunother cancer vol. 10,11 Nov 7 2022; e004974. doi:10.1136/jitc-2022-004974.